The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Specific mutations in Methyl-CpG-Binding Protein 2 confer different severity in Rett syndrome
Open accessAbstract
Objective To determine if a relationship exists between the clinical features of Rett syndrome, an X-linked dominant neurodevelopmental disorder, and specific mutations in MECP2. Method Cross-sectional study of 245 girls and women with typical Rett syndrome seen between 1990 and 2004 in tertiary academic outpatient specialty clinics and who had complete MECP2 mutation analysis. A structured clinical evaluation was completed for each participant. The results were grouped by MECP2 mutation and compared. Results Participants with the R133C mutation are less severely affected than those with R168X or large DNA deletions (p Conclusions Specific mutations in MECP2 confer different severity. These results allow the design of therapies targeted toward the amelioration of expected problems. Furthermore, the distinct effects of MECP2 mutations on clinical severity must be considered in clinical intervention trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Therefore, MECP2 mutation status is a strong predictor of disease severity, but phenotype variation commonly occurs between individuals with the same MECP2 mutation and is attributed to differences in X chromosome inactivation (XCI) [97].”
From Rett syndrome: a neurological disorder with metabolic components (2018) · cites this paper as [38]
In the citing paper
“It is now well established that mutations in MECP2 account for 95% of typical RTT cases and commonly occur de novo [36–38].”
From Rett syndrome: a neurological disorder with metabolic components (2018) · cites this paper as [38]
In the citing paper
“It is now well established that mutations in MECP2 account for 95% of typical RTT cases and commonly occur de novo [36–38].”
From Rett syndrome: a neurological disorder with metabolic components (2018) · cites this paper as [38]
In the citing paper
“Rett syndrome (RTT) is a neurological disorder caused by mutations in the X-linked gene methyl-CpG-binding protein 2 (MECP2), a ubiquitously expressed transcriptional regulator.”
From Rett syndrome: a neurological disorder with metabolic components (2018) · cites this paper as [38]
Citations
Cites
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
Self-citationAllen, R. C., Zoghbi, H. Y., Moseley, A., Rosenblatt, H. M., & Belmont, J. W. (1992) · PubMed · Cited by 1,683
Self-citationAn update on clinically applicable diagnostic criteria in Rett syndrome
Hagberg, B. A., Hanefeld, F. A., Percy, A. K., & Skjeldal, O. H. (2002) · European Journal of Paediatric Neurology · doi:10.1053/ejpn.2002.0612 · Cited by 394
Self-citationInfluence of mutation type and X chromosome inactivation on Rett syndrome phenotypes
Amir, R. E., den Veyver, I. B. V., Schultz, R., Malicki, D. M., Tran, C. Q., Dahle, E. J., Philippi, A., Tímár, L., Percy, A. K., Motil, K. J., et al. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200005)47:5 · Cited by 351
Self-citationRett syndrome in Australia: A review of the epidemiology
Laurvick, C. L., de Klerk, N. H., Bower, C. I., Christodoulou, J., Ravine, D., Ellaway, C., Williamson, S. L., & Leonard, H. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.10.037 · Cited by 345
Williams syndrome: From genotype through to the cognitive phenotype
Donnai, D., & Karmiloff‐Smith, A. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(200022)97:2 · Cited by 314
Self-citationMECP2 mutations account for most cases of typical forms of Rett syndrome
Bienvenu, T. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1377 · Cited by 303
Cheadle, J. P. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.7.1119 · Cited by 288
MECP2 is highly mutated in X-linked mental retardation
Couvert, P. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.9.941 · Cited by 272
Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients
Huppke, P. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1369 · Cited by 246
Research works printed but not linked: 1
- Zar JH. Biostatistical Analysis. In: Biostatistical Analysis. 4th ed. Englewood Cliffs NJ: Prentice-Hall; 1998: 564.
Cited by
Sorted by citations
Items 201–300 of 499
Assessment of Caregiver Inventory for Rett Syndrome
Lane, J. B., Salter, A. R., Jones, N. E., Cutter, G., Horrigan, J. P., Skinner, S. A., Kaufmann, W. E., Glaze, D. G., Neul, J. L., & Percy, A. K. (2017) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-017-3034-3 · Cited by 25
Self-citationMeCP2 and transcriptional control of eukaryotic gene expression
Akhtar, G. B., Buist, M., & Rastegar, M. (2022) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2022.151237 · Cited by 24
Clinical Phenotype of 5 Females With a CDKL5 Mutation
Stalpers, X. L., Spruijt, L., Yntema, H. G., & Verrips, A. (2011) · Journal of Child Neurology · doi:10.1177/0883073811413832 · Cited by 24
Detection of neurophysiological features in female R255X MeCP2 mutation mice
Dong, H., Erickson, K. R., Lee, J. R., Merritt, J. K., Fu, C., & Neul, J. L. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105083 · Cited by 22
Self-citationAssessment of the gut bacterial microbiome and metabolome of girls and women with Rett Syndrome
Thapa, S., Venkatachalam, A., Khan, N., Naqvi, M., Balderas, M. A., Runge, J. K., Haag, A. M., Hoch, K. M., Glaze, D. G., Luna, R. A., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251231 · Cited by 23
Self-citationMeCP2 and Major Satellite Forward RNA Cooperate for Pericentric Heterochromatin Organization
Fioriniello, S., Csukonyi, E., Marano, D., Brancaccio, A., Madonna, M., Zarrillo, C., Romano, A., Marracino, F., Matarazzo, M. R., D’Esposito, M., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.11.006 · Cited by 22
Differential dynamics specify MeCP2 function at nucleosomes and methylated DNA
Chua, G. N. L., Watters, J. W., Olinares, P. D. B., Begum, M., Vostal, L. E., Luo, J. A., Chait, B. T., & Liu, S. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-024-01373-9 · Cited by 25
Effect of desipramine on patients with breathing disorders in RETT syndrome
Mancini, J., Dubus, J. ‐., Jouve, É., Roux, J., Franco, P., Lagrue, E., Castelnau, P., Cancès, C., Chaix, Y., Rougeot, C., et al. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.468 · Cited by 22
A New Scale to Evaluate Motor Function in Rett Syndrome: Validation and Psychometric Properties
Roidi, M. L. R., Isaias, I. U., Cozzi, F., Grange, F., Scotti, F. M., Gestra, V. F., Gandini, A., & Ripamonti, E. (2019) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2019.03.005 · Cited by 23
Unterman, I., Bloch, I., Cazacu, S., Kazimirsky, G., Berman, B. P., Ben‐Zeev, B., Brodie, C., & Tabach, Y. (2021) · eLife · doi:10.7554/elife.67085 · Cited by 21
Venkateswaran, S., McMillan, H. J., Doja, A., & Humphreys, P. (2013) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.12334 · Cited by 22
Cortelazzo, A., Felice, C. D., Leoncini, S., Signorini, C., Guerranti, R., Leoncini, R., Armini, A., Bini, L., Ciccoli, L., & Hayek, J. (2016) · Inflammation Research · doi:10.1007/s00011-016-1014-2 · Cited by 21
Familial cases and male cases with MECP2 mutations
Zhang, Q., Zhao, Y., Bao, X., Luo, J. J., Zhang, X., Li, J., Wei, L., & Wu, X. (2017) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32534 · Cited by 22
Smirnov, K., Stroganova, T. A., Molholm, S., & Sysoeva, O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105308 · Cited by 21
Young, D. J., Bebbington, A., de Klerk, N. H., Bower, C. I., Nagarajan, L., & Leonard, H. (2010) · Research in Autism · doi:10.1016/j.rasd.2010.06.007 · Cited by 22
Neurophysiology versus clinical genetics in Rett syndrome: A multicenter study
Halbach, N. S. J., Smeets, E., Julu, P. O. O., Witt‐Engerström, I., Pini, G., Bigoni, S., Hansen, S., Apartopoulos, F., Delamont, R. S., van Roozendaal, K. E. P., et al. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37812 · Cited by 21
Zaghlula, M., Glaze, D. G., Enns, G. M., Potocki, L., Schwabe, A. L., & Suter, B. (2018) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38689 · Cited by 21
Self-citationSysoeva, O., Smirnov, K., & Stroganova, T. A. (2019) · Clinical Neurophysiology · doi:10.1016/j.clinph.2019.11.003 · Cited by 19
Cordone, V., Ferrara, F., Pecorelli, A., Guiotto, A., Vitale, A., Amicarelli, F., Cervellati, C., Hayek, J., & Valacchi, G. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.01.017 · Cited by 21
Improving clinical trial readiness to accelerate development of new therapeutics for Rett syndrome
Leonard, H., Gold, W. A., Samaco, R. C., Şahin, M., Benke, T. A., & Downs, J. A. (2022) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-022-02240-w · Cited by 21
Comparison of evoked potentials across four related developmental encephalopathies
Saby, J. N., Peters, S. U., Benke, T. A., Standridge, S. M., Swanson, L. C., Lieberman, D. N., Olson, H. E., Key, A. P. F., Percy, A. K., Neul, J. L., et al. (2023) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-023-09479-9 · Cited by 20
Self-citationMaffei, S., Felice, C. D., Cannarile, P., Leoncini, S., Signorini, C., Pecorelli, A., Montomoli, B., Lunghetti, S., Ciccoli, L., Durand, T., et al. (2014) · Mediators of Inflammation · doi:10.1155/2014/983178 · Cited by 20
Caffarelli, C., Gonnelli, S., Pitinca, M. D. T., Camarri, S., Refaie, A. F. A., Hayek, J., & Nuti, R. (2020) · BMC Medical Genetics · doi:10.1186/s12881-020-0960-2 · Cited by 20
Transcriptomic and Epigenomic Landscape in Rett Syndrome
Marano, D., Fioriniello, S., D’Esposito, M., & Ragione, F. D. (2021) · Biomolecules · doi:10.3390/biom11070967 · Cited by 24
Gonçalez, J. L., Shen, J., & Li, W. (2024) · Cells · doi:10.3390/cells13242077 · Cited by 21
Takeguchi, R., Kuroda, M., Tanaka, R., Suzuki, N., Akaba, Y., Tsujimura, K., Itoh, M., & Takahashi, S. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120381 · Cited by 19
Efficacy and tolerance of cannabidiol in the treatment of epilepsy in patients with Rett syndrome
Desnous, B., Beretti, T., Muller, N., Neveu, J., Villeneuve, N., Lepine, A. F., Daquin, G., & Milh, M. (2023) · Epilepsia Open · doi:10.1002/epi4.12796 · Cited by 19
The Rare Diseases Clinical Research Network: a model for clinical trial readiness
Lumsden, J. M., & Urv, T. K. (2023) · Therapeutic Advances in Rare Disease · doi:10.1177/26330040231219272 · Cited by 22
Rett Syndrome and the Role of MECP2: Signaling to Clinical Trials
Lopes, A. M. A. D. P., Loganathan, S. K., & Caliaperumal, J. (2024) · Brain Sciences · doi:10.3390/brainsci14020120 · Cited by 19
Brašić, J. R., Bibat, G., Kumar, A., Zhou, Y., Hilton, J., Yablonski, M. E., DOĞAN, A. S., Guevara, M. R., Stephane, M., Johnston, M. V., et al. (2011) · Synapse · doi:10.1002/syn.21515 · Cited by 19
MeCP2 Dysfunction in Rett Syndrome and Neuropsychiatric Disorders
Chin, E., & Goh, E. L. K. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9554-7_33 · Cited by 20
Longitudinal Hand Function in Rett Syndrome
Downs, J. A., Bebbington, A., Kaufmann, W. E., & Leonard, H. (2010) · Journal of Child Neurology · doi:10.1177/0883073810381920 · Cited by 19
Clinical and Electroencephalographic Effects of Folinic Acid Treatment in Rett Syndrome Patients
Hagebeuk, E. E. O., Koelman, J. H. T. M., Durán, M., Abeling, N. G. G. M., Vyth, A., & Poll‐The, B. T. (2011) · Journal of Child Neurology · doi:10.1177/0883073810390037 · Cited by 19
Altered Bone Status in Rett Syndrome
Pecorelli, A., Cordone, V., Schiavone, M. L., Caffarelli, C., Cervellati, C., Cerbone, G., Gonnelli, S., Hayek, J., & Valacchi, G. (2021) · Life · doi:10.3390/life11060521 · Cited by 18
Initial assessment of the StepWatch Activity Monitor™ to measure walking activity in Rett syndrome
Downs, J. A., Leonard, H., & Hill, K. (2011) · Disability and Rehabilitation · doi:10.3109/09638288.2011.630773 · Cited by 18
Bisgaard, A.-M., Schönewolf-Greulich, B., Ravn, K., & Rønde, G. (2015) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2015.07.004 · Cited by 17
Stahlhut, M., Downs, J. A., Wong, K., Bisgaard, A., & Nordmark, E. (2019) · Physical Therapy · doi:10.1093/ptj/pzz138 · Cited by 17
Rett Syndrome: Coming to Terms with Treatment
Percy, A. K. (2014) · Advances in Neuroscience · doi:10.1155/2014/345270 · Cited by 17
Self-citationAutism Spectrum Disorder and Epilepsy: Pathogenetic Mechanisms and Therapeutic Implications
Giliberti, A., Frisina, A. M., Giustiniano, S., Carbonaro, Y., Roccella, M., & Nardello, R. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14072431 · Cited by 18
Ivy, A. S., & Standridge, S. (2021) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2021.100881 · Cited by 16
Loss of O-GlcNAcylation on MeCP2 at Threonine 203 Leads to Neurodevelopmental Disorders
Cheng, J., Zhao, Z., Chen, L., Li, Y., Du, R., Wu, Y., Zhu, Q., Fan, M., Duan, X., & Wu, H. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00784-8 · Cited by 16
Oberman, L. M., Leonard, H., Downs, J. A., Cianfaglione, R., Stahlhut, M., Larsen, J. L., Madden, K. V., & Kaufmann, W. E. (2023) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944-7558-128.3.237 · Cited by 16
Convergent synaptic and circuit substrates underlying autism genetic risks
McGee, A. W., Li, G., Lu, Z., & Qiu, S. (2014) · Frontiers in Biology · doi:10.1007/s11515-014-1298-y · Cited by 17
Longitudinal bone mineral content and density in Rett syndrome and their contributing factors
Jefferson, A., Fyfe, S., Downs, J. A., Woodhead, H., Jacoby, P. A., & Leonard, H. (2015) · Bone · doi:10.1016/j.bone.2015.01.023 · Cited by 16
Coaching Communication Partners
Bartolotta, T. E., & Remshifski, P. A. (2012) · Communication Disorders Quarterly · doi:10.1177/1525740112453165 · Cited by 16
Tordjman, S., Cohen, D., Coulon, N., Anderson, G. M., Botbol, M., Canitano, R., & Roubertoux, P. L. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.030 · Cited by 19
Pubertal trajectory in females with Rett syndrome: A population-based study
Knight, O., Bebbington, A., Siafarikas, A., Woodhead, H., Girdler, S. J., & Leonard, H. (2012) · Brain and Development · doi:10.1016/j.braindev.2012.11.007 · Cited by 16
MeCP2 ubiquitination and sumoylation, in search of a function
Kalani, L., Kim, B.-H., Vincent, J. B., & Ausió, J. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad150 · Cited by 14
Stahlhut, M., Downs, J. A., Aadahl, M., Leonard, H., Bisgaard, A., & Nordmark, E. (2017) · Disability and Rehabilitation · doi:10.1080/09638288.2017.1381181 · Cited by 15
Oral health experiences of individuals with Rett syndrome: a retrospective study
Lai, Y. Y. L., Wong, K., King, N. M., Downs, J. A., & Leonard, H. (2018) · BMC Oral Health · doi:10.1186/s12903-018-0651-y · Cited by 15
Parkinsonism, Intellectual Disability, and Catatonia in a Young Male With MECP2 Variant
Pollini, L., Galosi, S., Nardecchia, F., Musacchia, F., Castello, R., Nigro, V., & Leuzzi, V. (2019) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12865 · Cited by 15
Gomes, A. R., Fernandes, T. G., Cabral, J. M. S., & Diogo, M. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073751 · Cited by 15
Gene therapy for Rett syndrome
Bassuk, A. G. (2021) · Genes Brain & Behavior · doi:10.1111/gbb.12754 · Cited by 15
Decline in gross motor skills in adult Rett syndrome; results from a Danish longitudinal study
Bisgaard, A., Wong, K., Højfeldt, A., Larsen, J. L., Schönewolf‐Greulich, B., Rønde, G., Downs, J. A., & Stahlhut, M. (2021) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62429 · Cited by 16
Mao, Y., Evans, E. E., Mishra, V. A., Balch, L., Eberhardt, A., Zauderer, M., & Gold, W. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179465 · Cited by 15
Hagebeuk, E. E. O., Durán, M., Abeling, N. G. G. M., Vyth, A., & Poll‐The, B. T. (2013) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-013-9590-6 · Cited by 15
Hagebeuk, E. E. O., Durán, M., Koelman, J. H. T. M., Abeling, N. G. G. M., Vyth, A., & Poll‐The, B. T. (2011) · Journal of Child Neurology · doi:10.1177/0883073811417184 · Cited by 15
The role of MeCP2 in learning and memoryPreprint
Robinson, H., & Pozzo‐Miller, L. D. (2019) · Learning & Memory · doi:10.1101/lm.048876.118 · Cited by 16
Blood–Brain Barrier Integrity Is Perturbed in a Mecp2-Null Mouse Model of Rett Syndrome
Pepe, G., Fioriniello, S., Marracino, F., Capocci, L., Maglione, V., D’Esposito, M., Pardo, A. D., & Ragione, F. D. (2023) · Biomolecules · doi:10.3390/biom13040606 · Cited by 14
Rett syndrome: a review of clinical manifestations and therapeutic approaches
Bricker, K., & Vaughn, B. V. (2024) · Frontiers in Sleep · doi:10.3389/frsle.2024.1373489 · Cited by 19
Shen, X., Yeung, H. T., & Lai, K. (2018) · Developmental Neurobiology · doi:10.1002/dneu.22644 · Cited by 14
Graded and pan-neural disease phenotypes of Rett Syndrome linked with dosage of functional MeCP2
Chen, X., Han, X., Blanchi, B., Guan, W., Ge, W., Yu, Y., & Sun, Y. E. (2020) · Protein & Cell · doi:10.1007/s13238-020-00773-z · Cited by 14
WGCNA Identifies Translational and Proteasome-Ubiquitin Dysfunction in Rett Syndrome
Haase, F., Gloss, B., Tam, P., & Gold, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189954 · Cited by 12
Anthropometric Measures Correspond with Functional Motor Outcomes in Females with Rett Syndrome
Motil, K. J., Geerts, S. P., Annese, F., Neul, J. L., Benke, T. A., Marsh, E. D., Lieberman, D. N., Skinner, S. A., Glaze, D. G., Heydemann, P. T., et al. (2022) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2022.01.009 · Cited by 15
Self-citationGenetically determined encephalopathy
Bahi‐Buisson, N. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52891-9.00031-2 · Cited by 14
Synaptic Plasticity as a Therapeutic Target in the Treatment of Autism-related Single-gene Disorders
Pignatelli, M., Feligioni, M., Piccinin, S., Molinaro, G., Nicoletti, F., & Nisticò, R. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319360008 · Cited by 14
Adult Interpretations of Communicative Behavior in Learners with Rett Syndrome
Julien, H. M., Parker-McGowan, Q., Byiers, B. J., & Reichle, J. E. (2014) · Journal of Developmental and Physical Disabilities · doi:10.1007/s10882-014-9407-z · Cited by 14
Hendrie, D. V., Bebbington, A., Bower, C. I., & Leonard, H. (2010) · Research in Autism · doi:10.1016/j.rasd.2010.10.004 · Cited by 14
Vermudez, S. A. D., Gogliotti, R. G., Arthur, B., Buch, A. B., Morales, C. D., Moxley, Y., Rajpal, H., Conn, P. J., & Niswender, C. M. (2021) · Genes Brain & Behavior · doi:10.1111/gbb.12752 · Cited by 13
Vitamin D Deficiency in Serbian Patients With Rett Syndrome
Sarajlija, A., Djurić, M., Kisić-Tepavčević, D., Grković, S., & Djordjevic, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2627 · Cited by 15
Hung, P., Wu, K. L. H., Chen, C., Siu, K.-K., Hsin, Y., Wang, L., & Wang, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137174 · Cited by 15
Endocrine disorders in Rett syndrome: a systematic review of the literature
Pepe, G., Coco, R., Corica, D., Luppino, G., Morabito, L. A., Lugarà, C., Abbate, T., Zirilli, G., Aversa, T., Stagi, S., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1477227 · Cited by 16
Moss, J. F., & Howlin, P. (2009) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 13
Fabio, R. A., Martino, G., Caprì, T., Giacchero, R., Giannatiem, S., Antonietti, A., Briola, F. L., Banderali, G., Canevini, M. P., & Vignoli, A. (2017) · Asian Journal of Clinical Nutrition · doi:10.3923/ajcn.2018.37.46 · Cited by 13
Leoncini, S., Signorini, C., Boasiako, L., Scandurra, V., Hayek, J., Ciccoli, L., Rossi, M., Canitano, R., & Felice, C. D. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.833239 · Cited by 13
Sleep problems in individuals with Rett Syndrome: A systematic review and meta-analysis
Spruyt, K. (2022) · Sleep Epidemiology · doi:10.1016/j.sleepe.2022.100027 · Cited by 13
Pascual‐Alonso, A., Xiol, C., Smirnov, D., Kopajtich, R., Prokisch, H., & Armstrong, J. (2023) · Human Genomics · doi:10.1186/s40246-023-00532-1 · Cited by 16
Functional outcomes in Rett syndrome
Pidcock, F. S., Salorio, C. F., Bibat, G., Swain, J. O., Scheller, J. M., Shore, W. S., & Naidu, S. (2015) · Brain and Development · doi:10.1016/j.braindev.2015.06.005 · Cited by 13
Blood oxidative stress and metallothionein expression in Rett syndrome: Probing for markers
Pintaudi, M., Veneselli, E., Voci, A., Vignoli, A., Castiglione, D., Calevo, M. G., Grasselli, E., Ragazzoni, M., Cogliati, F., Calzari, L., et al. (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1077990 · Cited by 13
A Plasma Proteomic Approach in Rett Syndrome: Classical versus Preserved Speech Variant
Cortelazzo, A., Guerranti, R., Felice, C. D., Signorini, C., Leoncini, S., Pecorelli, A., Landi, C., Bini, L., Montomoli, B., Sticozzi, C., et al. (2013) · Mediators of Inflammation · doi:10.1155/2013/438653 · Cited by 12
Záhoráková, D., Lelková, P., Gregor, V., Magner, M., Zeman, J., & Pavel Martasek, E. (2016) · Journal of Human Genetics · doi:10.1038/jhg.2016.19 · Cited by 14
Minárovits, J., & Niller, H. H. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3345-3 · Cited by 13
A rare male patient with classic Rett syndrome caused by MeCP2_e1 mutation
Tokaji, N., Ito, H., Kohmoto, T., Naruto, T., Takahashi, R., Goji, A., Mori, T., Toda, Y., Saitō, M., Tange, S., et al. (2018) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38595 · Cited by 13
Genetic and Epileptic Features in Rett Syndrome
Kim, H. J., Kim, S. H., Kim, H. D., Lee, J. S., Lee, Y., Koo, K. Y., Lee, J., & Kang, H. (2012) · Yonsei Medical Journal · doi:10.3349/ymj.2012.53.3.495 · Cited by 13
Effects ofω-3 Polyunsaturated Fatty Acids on Plasma Proteome in Rett Syndrome
Felice, C. D., Cortelazzo, A., Signorini, C., Guerranti, R., Leoncini, S., Pecorelli, A., Durand, T., Galano, J., Oger, C., Zollo, G., et al. (2013) · Mediators of Inflammation · doi:10.1155/2013/723269 · Cited by 13
Psychometric Assessment of the Rett Syndrome Caregiver Assessment of Symptom Severity (RCASS)
Raspa, M., Gwaltney, A. Y., Bann, C., von Hehn, J., Benke, T. A., Marsh, E. D., Peters, S. U., Ananth, A., Percy, A. K., & Neul, J. L. (2024) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-024-06238-0 · Cited by 12
Self-citationSaby, J. N., Mulcahey, P. J., Benke, T. A., Peters, S. U., Standridge, S. M., Lieberman, D. N., Key, A. P. F., Percy, A. K., Nelson, C. A., Roberts, T. P. L., et al. (2024) · Annals of Neurology · doi:10.1002/ana.26948 · Cited by 11
Self-citationEpigenetics in rare neurological diseases
Roberts, C.-T., Arezoumand, K. S., Shahib, A. K., Davie, J., & Rastegar, M. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1413248 · Cited by 16
Martin, P. (2017) · Advances in Autism · doi:10.1108/aia-02-2017-0003 · Cited by 11
Romano, A., Ippolito, E., Risoli, C., Malerba, E., Favetta, M., Sancesario, A., Lotan, M., & Moran, D. S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030559 · Cited by 12
A novel mutation R190H in the AT-hook 1 domain of MeCP2 identified in an atypical Rett syndrome
Zhou, X., Liao, Y., Xu, M., Ji, Z., Xu, Y., Zhou, L., Wei, X., Hu, P., Han, P., Yang, F., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18955 · Cited by 11
Developing AAV-delivered nonsense suppressor tRNAs for neurological disorders
Wang, J., Gao, G., & Wang, D. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00391 · Cited by 10
Rett syndrome: The Natural History Study journey
Percy, A. K., Benke, T. A., Marsh, E. D., & Neul, J. L. (2024) · Annals of the Child Neurology Society · doi:10.1002/cns3.20086 · Cited by 13
Self-citationDowns, J. A., Wong, K., & Leonard, H. (2024) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-024-09575-4 · Cited by 11
Downs, J. A., Pichard, D. C., Kaufmann, W. E., Horrigan, J. P., Raspa, M., Townend, G. S., Marsh, E. D., Leonard, H., Motil, K. J., Dietz, A. C., et al. (2024) · Trials · doi:10.1186/s13063-024-08678-6 · Cited by 11
Self-citationSantosh, P., Lievesley, K., Fiori, F., & Singh, J. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015342 · Cited by 11
Li, D., Mei, L., Li, H., Hu, C., Zhou, B., Zhang, K., Qiao, Z., Xu, X., & Xu, Q. (2022) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2022.962197 · Cited by 10
Gold, W. A., & Christodoulou, J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00266 · Cited by 12
Fisher, N. M., Gogliotti, R. G., Vermudez, S. A. D., Stansley, B. J., Conn, P. J., & Niswender, C. M. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00414 · Cited by 11
Molecular Context-Dependent Effects Induced by Rett Syndrome-Associated Mutations in MeCP2
Ortega-Alarcón, D., Claveria‐Gimeno, R., Vega, S., Jorge-Torres, O. C., Esteller, M., Abián, O., & Velázquez‐Campoy, A. (2020) · Biomolecules · doi:10.3390/biom10111533 · Cited by 11
Metadata
- Authors
- Neul, J. L., Fang, P., Barrish, J., Lane, J., Caeg, E. B., Smith, E. O., Zoghbi, H., Percy, A., & Glaze, D. G.
- Affiliations
- University of Alabama (US)
- Venue
- Neurology
- Published
- 2008-04-15
- Volume
- 70
- Issue
- 16
- Pages
- 1313-1321
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC2677974
- OpenAlex
- W2066619092
- Cited by
- 498
- References
- 38
- Citations by year
- 2026: 19 · 2025: 29 · 2024: 45 · 2023: 33 · 2022: 23 · 2021: 35 · 2020: 29 · 2019: 24 · 2018: 24 · 2017: 27 · 2016: 30 · 2015: 29 · 2014: 23 · 2013: 33 · 2012: 20
- FWCI
- 14.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- University of Alabama at Birmingham
- National Institute of Neurological Disorders and Stroke (K08NS052240, NS057819, T32NS043124, NS43124, NS052240, R01NS057819)
- National Center for Research Resources (U54RR019478, RR-019478, RR 00188, K01RR000188, M01RR000188)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD-38985, P30HD038985, HD40301, P01HD040301)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Keywords
- Rett syndrome, MECP2 mutations, clinical severity, DNA deletion, ambulation, hand use, language development
- MeSH terms
- Cross-Sectional Studies, Female, Humans, Mutation, Severity of Illness Index, Rett Syndrome, Methyl-CpG-Binding Protein 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review